Skip to main content
OpenTrials

Clinical trial condition

Diabetic Macular Edema

Explore clinical trials studying Diabetic Macular Edema. Study availability and eligibility vary by location and protocol.

349 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Diabetic Macular Edema trial results

Completed

A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)

NCT06723288

Conditions
Diabetic Macular Edema, Neovascular Age-related Macular Degeneration
Locations
  • Hospital Universitario de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital General de Catalunya San Cugat Del Valles, Barcelona, Spain
  • Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
  • Clinica Universitaria de Navarra Pamplona, Navarre, Spain
View all 20 locations
View Trial Details
Completed

A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema

NCT04432831

Conditions
Diabetic Macular Edema
Locations
  • Barnet Dulaney Perkins Eye Center Mesa, Arizona, United States
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Arizona Retina and Vitreous Consultants Phoenix, Arizona, United States
  • Retina Associates Southwest PC Tucson, Arizona, United States
View all 320 locations
View Trial Details
Completed

A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

NCT06591598

Conditions
Diabetic Macular Edema, Neovascular Age-related Macular Degeneration
Locations
  • Fakultní nemocnice Královské Vinohrady - Urologická klinikay Prague, Czechia
  • Axon Clinical, s.r.o. Prague, Czechia
  • Budapest Retina Associates Budapest, Hungary
  • Debreceni Egyetem Klinikai Kozpont Debrecen, Hungary
View Trial Details
Completed

A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema

NCT05151744

Conditions
Diabetic Macular Edema
Locations
  • Win Retina Arcadia, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance, California, United States
  • Bay Area Retina Associates Walnut Creek, California, United States
  • Florida Eye Associates Melbourne, Florida, United States
View all 38 locations
View Trial Details
Completed

A Single Ascending Dose Cohort Study of AG-73305 in DME Patients

NCT05301751

Conditions
Diabetic Macular Edema
Locations
  • Retina Vitreous Associates of Florida St. Petersburg, Florida, United States
  • Center of Macula and Retina Disease Winter Haven, Florida, United States
  • Retina Research Institute of Texas Abilene, Texas, United States
  • Texas Retina Associates Fort Worth, Texas, United States
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)

NCT05712720

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +10 more
Locations
  • Rezolute Investigative Site, Phoenix, Arizona Phoenix, Arizona, United States
  • Rezolute Investigative Site, Bakersfield, CA Bakersfield, California, United States
  • Rezolute Investigative Site, Beverly Hills, California Beverly Hills, California, United States
  • Rezolute Investigative Site, Fullerton, California Fullerton, California, United States
View all 32 locations
View Trial Details
Completed

A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema

NCT05511038

Conditions
Diabetic Macular Edema
Locations
  • L.V. Prasad Eye Institute Hyderabad, Andhra Pradesh, India
  • M & J Western Regional Institute of Ophthalmology Ahmedabad, Gujarat, India
  • Raghudeep Eye Hospital Ahmedabad, Gujarat, India
  • Narayana Nethralaya Bengaluru, Karnataka, India
View Trial Details
Completed

Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema

NCT05697809

Conditions
Diabetic Macular Edema, Edema, Eye Diseases, +7 more
Locations
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Blue Ocean Clinical Research West Clearwater, Florida, United States
  • University Retina and Macula Associates Oak Forest, Illinois, United States
  • Retina Consultants of Minnesota Minneapolis, Minnesota, United States
View Trial Details

Related conditions